drugset / Trial / NCT03012386

CD36 in Nutrient Delivery and Its Dysfunction

NCT03012386

NaSingle-groupOpen-labelBasic science

Summary

This proposal will test the hypothesis that chronic treatment with sildenafil with and without the use of nitric oxide substrate, L-arginine, protects against fatty acid induced impairment of endothelial function, improves insulin-stimulated microvascular recruitment, insulin sensitivity and glucose uptake in CD36 rs3211938 G-allele carriers.

Timeline

Start
2017-01
Primary completion
2021-07
Completion
2021-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 20 mg

Indications

No indication recorded.